In the fast-growing diagnostics testing market, Hologic HOLX and Quest Diagnostics DGX stand out as two prominent players, ...
The broad EM equity rally has now entered a more structurally supportive phase rather than a pure sentiment bounce.
In the KEYNOTE-B96 trial ( NCT05116189 ), weekly paclitaxel with bevacizumab and pembrolizumab (Keytruda; Merck) demonstrated ...
Key End Points for Providers to Consider With New Multiple Myeloma Therapies: Hearn Jay Cho, MD, PhD
Hearn Jay Cho, MD, PhD, chief medical officer at the Multiple Myeloma Research Foundation, shared insights on what end points ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback